In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany.

MLA

Kresken, Michael, et al. “In Vitro Activity of Gepotidacin against Urine Isolates of Escherichia Coli from Outpatient Departments in Germany.” Journal of Antimicrobial Chemotherapy (JAC), vol. 78, no. 2, Feb. 2023, pp. 418–22. EBSCOhost, https://doi.org/10.1093/jac/dkac406.

APA

Kresken, M., Wohlfarth, E., Weikel, C., Butler, D., Pfeifer, Y., Werner, G., & Therapy, “Antimicrobial Resistance” Study Group of the Paul Ehrlich Society for Infection. (2023). In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany. Journal of Antimicrobial Chemotherapy (JAC), 78(2), 418–422. https://doi.org/10.1093/jac/dkac406

Chicago

Kresken, Michael, Esther Wohlfarth, Chase Weikel, Deborah Butler, Yvonne Pfeifer, Guido Werner, and “Antimicrobial Resistance” Study Group of the Paul Ehrlich Society for Infection Therapy. 2023. “In Vitro Activity of Gepotidacin against Urine Isolates of Escherichia Coli from Outpatient Departments in Germany.” Journal of Antimicrobial Chemotherapy (JAC) 78 (2): 418–22. doi:10.1093/jac/dkac406.